ACEI/ARB Treatment May Benefit Patients With COVID-19 and Hypertension
Treatment of patients with hypertension who are infected with the severe acute respiratory syndrome coronavirus 2 with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers may improve clinical outcomes.